Steward Partners Investment Advisory, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$74,845
-38.8%
2,367
-21.0%
0.00%
-50.0%
Q2 2023$122,218
+22.1%
2,997
+11.6%
0.00%0.0%
Q1 2023$100,107
+36.9%
2,686
+28.1%
0.00%
+100.0%
Q4 2022$73,129
-45.4%
2,096
-12.2%
0.00%
-66.7%
Q3 2022$134,000
+8.9%
2,386
+0.8%
0.00%
+50.0%
Q2 2022$123,000
-21.2%
2,368
+10.2%
0.00%0.0%
Q1 2022$156,000
-24.3%
2,148
+23.2%
0.00%
-33.3%
Q4 2021$206,000
-13.4%
1,743
-1.6%
0.00%
-25.0%
Q3 2021$238,000
-19.9%
1,772
-3.4%
0.00%
-20.0%
Q2 2021$297,000
-99.9%
1,834
-35.8%
0.01%
+150.0%
Q1 2021$229,208,000
+1432450.0%
2,856
+861.6%
0.00%
Q4 2020$16,000
+300.0%
297
-25.8%
0.00%
Q1 2020$4,000
-69.2%
400
-55.6%
0.00%
Q4 2019$13,000
+8.3%
9000.0%0.00%
Q3 2019$12,000
+100.0%
900
+125.0%
0.00%
Q2 2019$6,000
-45.5%
4000.0%0.00%
-100.0%
Q3 2018$11,0004000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Discovery Value Fund 572,950$19,990,2265.79%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$39,952,2255.34%
MPM BioImpact LLC 455,238$15,883,2544.12%
ARK Investment Management 9,420,782$328,691,0842.85%
Atlas Venture Associates IX, LLC 10,000$348,9001.74%
Ghisallo Capital Management LLC 250,000$8,722,5001.55%
Nikko Asset Management Americas, Inc. 2,976,002$103,743,4301.49%
Prosight Management, LP 72,116$2,516,1271.37%
Rokos Capital Management LLP 826,063$28,391,7851.24%
Elmwood Wealth Management, Inc. 67,899$2,368,9961.18%
View complete list of INTELLIA THERAPEUTICS INC shareholders